Colorectal cancer screening.
Colorectal cancer causes significant morbidity and mortality in the United States. The incidence of colorectal cancer increases at age 50, approximately. Risk factors that have been identified include a personal history of colorectal cancer or adenomas, a family history of colon cancer or adenomas, inherited colorectal cancer syndromes, and long standing inflammatory bowel disease. Several screening tests have been developed for colorectal cancer prevention. Surveillance strategy is based on an individual's colorectal cancer risk. This article reviews fecal occult blood testing, flexible sigmoidoscopy, colonoscopy, barium enema, and genetic testing.
Borum
M L
ML
Division of Gastroenterology, Department of Medicine, George Washington University Medical Center, Washington, DC 20037, USA.
D001466:Barium Sulfate; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D003287:Contrast Media; D004733:Enema; D005194:Family Practice / Q000379:methods; D005820:Genetic Testing / Q000379:methods; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D017720:Molecular Epidemiology; D009017:Morbidity; D009780:Occult Blood; D011320:Primary Health Care / Q000379:methods; D012307:Risk Factors; D012812:Sigmoidoscopy; D014481:United States / Q000453:epidemiology
D003287:Contrast Media; D001466:Barium Sulfate